Insider Transactions in Q3 2021 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Open market or private sale
|
Direct |
13,610
-40.02%
|
$979,920
$72.5 P/Share
|
|
Aug 17
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,610
+17.3%
|
$911,870
$67.56 P/Share
|
|
Aug 15
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.0%
|
$55
$55.08 P/Share
|
|
Aug 15
2021
|
Merdad Parsey Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.01%
|
$55
$55.08 P/Share
|
|
Aug 15
2021
|
Brett A Pletcher EVP,Corp Affairs & Gen Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
32
+0.11%
|
$1,760
$55.08 P/Share
|
|
Aug 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
907
-4.26%
|
$62,583
$69.24 P/Share
|
|
Aug 10
2021
|
Diane E. Wilfong SVP, Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,480
+10.43%
|
-
|
|
Jul 24
2021
|
Johanna Mercier Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,425
-21.99%
|
$236,325
$69.02 P/Share
|
|
Jul 24
2021
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,505
+32.52%
|
-
|